Guiding Principles for Industry Leadership
December 5, 2025
By Helen Bristow
Sitting Down With… Rita Shaknovich, Chief Medical Officer at Agilent Technologies
4 min read
False
Research, trends, news, and views
December 5, 2025
By Helen Bristow
Sitting Down With… Rita Shaknovich, Chief Medical Officer at Agilent Technologies
4 min read
December 4, 2025
By Marwan Alsarraj
A sensitive, droplet-based approach for circulating tumor DNA analysis in precision oncology
3 min read
December 4, 2025
At AMP 2025, a South Korean research team outlined a multimodal approach that integrates CSF, DNA, and MRI data to enable early, noninvasive tumor classification.
1 min read
December 3, 2025
In this webinar, you’ll see real time-and-motion data comparing two NGS workflows (amplicon based Oncomine Dx Express Test* and hybrid capture based NGS workflow) for routine precision oncology,
6:00 pm - 7:00 pm GMT min read
December 3, 2025
A targeted assay, presented at AMP 2025, identifies disease-specific TAF1 variants that standard panels often miss.
3 min read
December 3, 2025
By Jessica Allerton
She’s seen the field transform – but her advice for young pathologists remains timeless: lead with curiosity and commitment
December 2, 2025
Michigan team finds cryptic leukemia-defining rearrangements missed by standard cytogenetics.
3 min read
November 28, 2025
By Helen Bristow
Sitting Down With... George Netto, Professor and Chair, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania
6 min read
November 28, 2025
By Jim Gallagher
HPV-DeepSeek identifies circulating HPV DNA, PIK3CA mutations, and integration events in pretreatment blood samples with high sensitivity and specificity.
3 min read
November 27, 2025
At AMP 2025, scientists from Indiana University presented data on a rapid, highly specific PCR assay for histoplasmosis, blastomycosis, and coccidioidomycosis.
2 min read
False
False
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
False